معرفی
Suvi Douglas is a doctoral researcher at the University of Helsinki within the Applied Tumor Genomics (ATG) group under the Doctoral Programme in Biomedicine. Her research focuses on hematology, leukemia, and genetic predisposition to cancer, particularly in identifying germline variants linked to hematological malignancies.
Research Trends: Analysis of her publications reveals a focus on genetic mechanisms in acute leukemias, colorectal cancer susceptibility, and inherited bone marrow failure syndromes. Subfields include molecular genetics, cancer predisposition, pediatric oncology, and biomedical research.
- 2023: Identified DHX40 as a candidate gene for colorectal and hematological neoplasia (Leukemia journal)
- 2023: Characterized ERCC6L2 disease progression to acute leukemia (Blood journal)
- 2022: Studied germline variants in acute lymphoblastic leukemia
- 2019: Defined ERCC6L2 mutations in inherited acute myeloid leukemia
Projects: Participates in projects funded by the Sigrid Jusélius Foundation (2024-2026) and the Academy of Finland (2022-2026), aiming to uncover novel insights into leukemia pathogenesis.
